Allergic rhinitis: the modern aspects of therapy

Ianov Iu.K.

Sankt-Peterburgskiĭ NII ukha, gorla, nosa i rechi

Riazantsev S.V.

Sankt-Peterburgskiĭ NII ukha, gorla, nosa i rechi Minzdrava Rossii

Artyushkin S.A.

North-Western state medical University. I. I. Mechnikov, St. Petersburg, Russia, 191015

ORCID: 0000-0003-4482-6157

Fanta I.V.

Saint Petersburg Research Institute of Ear, Throat, Nose and Speech, Ministry of Heath of the Russian Fderation, Saint Petersburg, Russia, 190013

Pavlova S.S.

Saint Petersburg Research Institute of Ear, Throat, Nose and Speech, Ministry of Heath of the Russian Fderation, Saint Petersburg, Russia, 190013

Allergic rhinitis: the modern aspects of therapy

Authors:

Ianov Iu.K., Riazantsev S.V., Artyushkin S.A., Fanta I.V., Pavlova S.S.

More about the authors

Journal: Russian Bulletin of Otorhinolaryngology. 2018;83(3): 56‑60

DOI: 10.17116/otorino201883356

Downloaded: 34

Download PDF (RU)

Contact the author

Table of contents

To cite this article:

Ianov IuK, Riazantsev SV, Artyushkin SA, Fanta IV, Pavlova SS. Allergic rhinitis: the modern aspects of therapy. Russian Bulletin of Otorhinolaryngology. 2018;83(3):56‑60. (In Russ.)
https://doi.org/10.17116/otorino201883356

Подписка 2025 (Russian Bulletin of Otorhinolaryngology)

Close metadata

Recommended articles:

Peak nasal inspiratory flow in the assessment of nasal airway obstruction. Russian Bulletin of Otorhinolaryngology. 2024;(4):47-53

Clinical and epidemiological features of atopic type of alopecia areata. Russian Journal of Clinical Dermatology and Venereology. 2024;(2):155-160

Halotherapy in rehabilitation of children. Regenerative Biotechnologies, Preventive, Digital and Predictive Medicine. 2024;(1):37-44

The main objectives of the present article were to systematize the modern views of the causes and risk factors of allergic rhinitis, to clarify the manner of its development, to define the leading etiological mechanism underling the pathogenesis of this condition, to consider the methods used for the diagnostics and the treatment of this disease, and to sum up the clinical experience with the use of Levocetirizine (Allerwey) for the management of allergic rhinitis. Special attention is given to the achievement and the maintenance of control of the persistent or intermittent forms of allergic rhinitis and to approaches to its treatment based on the medications registered in the Russian Federation.

Keywords:

nasal obstruction

rhinorrhea

allergic diseases

sensitization

atopy

H1- histamine blockers of the second generation

levocetirizine

Allerway

Authors:

Ianov Iu.K.

Sankt-Peterburgskiĭ NII ukha, gorla, nosa i rechi

Riazantsev S.V.

Sankt-Peterburgskiĭ NII ukha, gorla, nosa i rechi Minzdrava Rossii

Artyushkin S.A.

North-Western state medical University. I. I. Mechnikov, St. Petersburg, Russia, 191015

ORCID: 0000-0003-4482-6157

Fanta I.V.

Saint Petersburg Research Institute of Ear, Throat, Nose and Speech, Ministry of Heath of the Russian Fderation, Saint Petersburg, Russia, 190013

Pavlova S.S.

Saint Petersburg Research Institute of Ear, Throat, Nose and Speech, Ministry of Heath of the Russian Fderation, Saint Petersburg, Russia, 190013

List of references:

Allergicheskii rinit: etiologiya, patogenez, osobennosti farmakoterapii. Metodicheskie rekomendatsii. Sostaviteli: Ryazantsev S.V., Artyushkin S.A. SPb.: Poliforum Grupp; 2017. (In Russ.)
Bousquet J, Khaltaev N, Cruz AA, Denburg J, Fokkens WJ, Togias A, Zuberbier T, Baena-Cagnani CE, Canonica GW, van Weel C, Agache I, Allergic Rhinitis and its Impact on Asthma (ARIA) 2008 update (in collaboration with the World Health Organization, GA(2)LEN and AllerGen). Allergy. 2008;63(suppl 86):8-160.
Min YG. The pathophysiology, diagnosis and treatment of allergic rhinitis. Allergy, Asthma and Immunology Research. 2010;2:65-76. doi:10.4168/aair.2010.2.2.65
Lack G. Pediatric allergic rhinitis and comorbid disorders. Journal of Allergy and Clinical Immunology. 2001;108(suppl 1):9-15. doi:10.1067/mai.2001.115562
Zaitseva OV, Bardennikova SI. Allergicheskii rinit u detei (rol’ pediatra v diagnostike, lechenii i profilaktike). M.: Izdatel’stvo «Pero»; 2015. (In Russ.)
Prussin C, Metcalfe DD. IgE, mast cells, basophils, and eosinophils. Journal of Allergy and Clinical Immunology. 2003;111(suppl 2):486-494. doi:10.1016/j.jaci.2009.12.010
Bradding P, Roberts JA, Britten KM, Montefort S, Djukanovic R, Mueller R, et al. Interleukin-4, -5, and -6 and tumor necrosis factor-alpha in normal and asthmatic airways: evidence for the human mast cell as a source of these cytokines. American Journal of Respiratory Cell and Molecular Biology. 1994;10:471-480. doi:10.1165/ajrcmb.10.5.8179909
Okayama Y, Kawakami T. Development, migration, and survival of mast cells. Immunologic Research. 2006;34:97-115. doi:10.1385/ir:34:2:97
Bardenikova SI, Zaitseva OV, Snitko SYu, Dovgun OB, Malinovskaya VV, Parfenov VV. Ratsional’naya reabilitatsiya detei s allergicheskim rinitom pri rekurrentnykh infektsiyakh respiratornogo trakta. Lechashchii vrach. 2015;4:15 (In Russ.)
Radtsig EYu, Ermilova NV, Bogomil’skii MR. Zalozhennost’ nosa u detei: prichiny i sposoby lecheniya. Pediatriya. 2012;91:5. (In Russ.)
Potter PC. Levocetirizine is effective for symptom relief including nasal congestion in adolescent and adult (PAR) sensitized to house dust mites. Allergy. 2003;58:893-899. doi:10.1034/j.1398-9995.2003.00171.x
Simons FE, Prenner BM, Finn Jr A. Efficacy and safety of desloratadine in the treatment of perennial allergic rhinitis. Journal of Allergy and Clinical Immunology. 2003;111:6176-6122. doi:10.1067/mai.2003.168
Leynadier F, Mees K, Arendt C, Pinelli ME. Efficacy and safety of levocetirizine in seasonal allergic rhinitis. Acta Otorhinolaryngol Belg. 2001;55:305-312. doi:10.18535/jmscr/v5i3.190
Horak F, Stübner UP, Zieglmayer R, Harris AG Effect of desloratadine versus placebo on nasal airflow and subjective measures of nasal obstruction in subjects with grass pollen-induced allergic rhinitis in an allergen-exposure unit. Journal of Allergy and Clinical Immunology. 2002;109:956-961. doi:10.1067/mai.2002.124657
Grant JA, Riethuisen JM, Moulaert B, DeVos C. A double-blind, randomized, single-dose, crossover comparison of levocetirizine with ebastine, fexofenadine, loratadine, mizolastine, and placebo: Suppression of histamine-induced wheal-and-flare response during 24 hours in healthy male subjects. Annals of Allergy, Asthma & Immunology. 2002;88:190-197. doi:10.1016/s1081-1206(10)61995-3
Day JH, Briscoe MP, Rafeiro E, Ratz JD. Comparative Clinical Efficacy, Onset and Duration of Action of Levocetirizine and Desloratadine for Symptoms of Seasonal Allergic Rhinitis in Subjects Evaluated in the Environmental Exposure Unit (EEU). International Journal of Clinical Practice. 2004;58(2):109-118. doi:10.1111/j.1368-5031.2004.0117.x
Denham KJ, Boutsiouki P, Clough GF, Church MK. Comparison of the effects of desloratadine and levocetirizine on histamine- induced wheal, flare and itch in human skin. Inflammation Research. 2003;52:424-427. doi:10.1007/s00011-003-1193-5
Frossard N, Purohit A, Melac M, Pauli G. Comparative activity of levocetirizine and desloratadine 5 mg on histamine-induced skin wheal and flare responses during 24 h. Allergy. 2002;57(suppl 73):308 (Abstract). doi:10.1046/j.0306-5251.2001.01551.x
Triggiani M, Giannattasio G, Balestrieri B, Loffredo S, Forte V, Granata F. Phenotypical and functional heterogeneity of human lung macrophages. Clinical & Experimental Allergy Reviews. 2004;4:129-134. doi:10.1111/j.1472-9725.2004.00045.x
Thomson L, Blaylock MG, Sexton DW, Campbell A, Walsh GM: Cetirizine and levocetirizine inhibit eotaxin-induced eosinophil transendothelial migration through human dermal or lung microvascular endothelial cells. Clinical Experimental Allergy. 2002;32:1187-1192. doi:10.1046/j.1365-2745.2002.01444.x
Gutzmer R, Wittmann M, Kapp A, Werfel T. Direct immunomodulatory effects of levocetirizine on lymphocytes. Paris, France: Proceedings of the XXII Congress of the European Academy of Allergy and Clinical Immunology. 2003.
Wu P, Mitchell S, Walsh GM. A new antihistamine levocetirizine inhibits eosinophil adhesion to vascular cell adhesion molecule-I under flow conditions. Clinical Experimental Allergy. 2005;35:1073-1079. doi:10.1111/j.1365-2222.2005.02290.x
Menzies-Gow A, Ying S, Phipps S, Kay AB: Interactions between eotaxin, histamine and mast cells in early microvascular events associated with eosinophil recruitment to the site of allergic skin reactions in humans. Clinical Experimental Allergy. 2004;34:1276. doi:10.1111/j.1365-2222.2004.02014.x
Giustizieri ML, Albanesi C, Fluhr J, Gisondi P, Norgauer J, Girolomoni G. H histamine receptorl mediates inflammatory responses in human keratinocytes. Journal of Allergy and Clinical Immunology. 2004;114:1176-1182. doi:10.1016/j.jaci.2004.07.054
Ciprandi G, Cirillo I, Vizzaccaro A, Civardi E, Barberi S, Allen M, Marseglia GL. Desloratadine and levocetirizine improve nasal symptoms, airflow, and allergic inflammation in patients with perennial allergic rhinitis: a pilot study. International Immunopharmacology. 2005;5:13-14:1800-1808. doi:10.1016/j.intimp.2005.05.008

Close metadata